Products for Research Use Only

Nur77 antagonist 2

CAT: 0804-HY-179033Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-179033Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Nur77 antagonist 2 (Compound 12b) is an orally active Nur77 antagonist with a KD value of 0.42 μM. Nur77 antagonist 2 exhibits proliferative activity on liver cancer cells. Nur77 antagonist 2 stabilizes Nur77 by inhibiting its ubiquitin-proteasomal degradation, leading to Nur77-dependent apoptosis via the ASK1-JNK/p38 pathway. Nur77 antagonist 2 inhibits tumor growth in the HCCLM3 xenograft model. Nur77 antagonist 2 can be used for the study of hepatocellular carcinoma (HCC) [1].
UNSPSC
12352005
Target
Apoptosis; ASK1; JNK; Nuclear Hormone Receptor 4A/NR4A; p38 MAPK
Related Pathways
Apoptosis; MAPK/ERK Pathway; Vitamin D Related/Nuclear Receptor
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(N/N=C/C1=CC(C)=CC=C1)C(N2)=CC3=C2C=CC(NC4=NC=CC(C5=CC=NC=C5)=N4)=C3
Molecular Formula
C26H21N7O
Molecular Weight
447.49
References & Citations
[1]Hu S, et al. Design, synthesis, and evaluation of 5- ((4- (pyridin-3-yl) pyrimidin-2-yl) amino) -1H-indole-2-carboxamide derivatives as anti-HCC agents targeting Nur77. Bioorg Chem. 2025 Oct 18;167:109113.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Nur77/NR4A1